{"schema_version":"secwatch.filing_event.v1","accession":"0001453687-25-000077","form_type":"8-K","ticker":"RNAC","cik":"0001453687","company_name":"Cartesian Therapeutics, Inc.","filed_at":"2025-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.332545+00:00","generated_at":"2026-05-23T03:41:09.805910+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"confidence":"high","headline":"Cartesian Therapeutics CTO Metin Kurtoglu to depart May 1; will serve as consultant through April 2026","bullets":["CTO Metin Kurtoglu's employment ends May 1, 2025; consulting agreement runs through April 30, 2026.","Separation agreement includes 12 months salary, pro-rated bonus eligibility, and accelerated vesting of equity awards granted Jan 2, 2024.","Release of claims upon receipt of severance benefits as per employment agreement dated March 28, 2024.","No replacement named; Dr. Kurtoglu will remain in advisory role under consulting terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001453687-25-000077","json":"https://secwatch.observer/filing/0001453687-25-000077.json","markdown":"https://secwatch.observer/filing/0001453687-25-000077.md","text":"https://secwatch.observer/filing/0001453687-25-000077.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000077/0001453687-25-000077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000077/rnac-20250429.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T03:41:09.805910+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"43b4aa7367","claim":"Metin Kurtoglu departed as Chief Technology Officer at Cartesian Therapeutics, Inc..","evidence_excerpt":"Dr. Kurtoglu’s employment with the Company will end effective May 1, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000077/0001453687-25-000077-index.htm","confidence":0.95}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}